AGPAT2 antibody (AA 199-278)

Catalog No. ABIN6136640

Product Details anti-AGPAT2 Antibody

Target: AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Binding Specificity: AA 199-278

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This AGPAT2 antibody is un-conjugated

Application: Western Blotting (WB), Immunofluorescence (IF)

Sequence: IVPVVYSSFS SFYNTKKKFF TSGTVTVQVL EAIPTSGLTA ADVPALVDTC HRAMRTTFLH ISKTPQENGA TAGSGVQPAQ

Cross-Reactivity: Human, Mouse

Characteristics: Polyclonal Antibodies

Purification: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 199-278 of human AGPAT2 (NP_006403.2).

Isotype: IgG

Application Details

Application Notes: WB,1:500 - 1:2000,IF,1:50 - 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for AGPAT2

Target: AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Alternative Name: AGPAT2 (AGPAT2 Products)

Synonyms: AGPAT2 antibody, zgc:153984 antibody, 1-agpat2 antibody, bscl antibody, bscl1 antibody, lpaab antibody, lpaat-beta antibody, 1-AGPAT2 antibody, BSCL antibody, BSCL1 antibody, LPAAB antibody, LPAAT-beta antibody, 2510002J07Rik antibody, AV000834 antibody, 1-acylglycerol-3-phosphate O-acyltransferase 2 antibody, 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) antibody, AGPAT2 antibody, agpat2 antibody, Agpat2 antibody

Background: This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.,AGPAT2,1-AGPAT2,BSCL,BSCL1,LPAAB,LPAAT-beta,Cancer,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Lipids,Fatty Acids,AGPAT2

Molecular Weight: 27 kDa/30 kDa

Gene ID: 10555

UniProt: O15120